12 Month Price Forecast For GLRE
Distance to GLRE Price Forecasts
GLRE Price Momentum
๐ค Considering Greenlight Re (GLRE)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 16, 2025 3:39 AM UTC
GLRE Analyst Ratings & Price Targets
GLRE has shown a year-to-date change of -3.4% and a 1-year change of 14.1%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for GLRE. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
GLRE Analyst Consensus
GLRE Price Target Range
Latest GLRE Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for GLRE.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Feb 23, 2018 | UBS | Buy | Maintains | $25.00 | |
Sep 2, 2015 | UBS | Buy | Maintains | $34.00 | |
Feb 19, 2015 | Keefe Bruyette & Woods | Outperform | Maintains | $0.00 | |
Feb 19, 2015 | Keefe, Bruyette & Woods | Outperform | Maintains | $38.00 | |
Jul 28, 2014 | Keefe Bruyette & Woods | Outperform | Initiates | $0.00 | |
Jul 28, 2014 | Keefe, Bruyette & Woods | Outperform | Initiates | $0.00 | |
Nov 21, 2012 | UBS | Buy | Upgrade | $27.00 |
Stocks Similar to Greenlight Capital Re, Ltd.
The following stocks are similar to Greenlight Re based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Greenlight Capital Re, Ltd. (GLRE) Financial Data
Greenlight Capital Re, Ltd. has a market capitalization of $470.94M with a P/E ratio of 5.3x. The company generates $702.25M in trailing twelve-month revenue with a 12.5% profit margin.
Revenue growth is +7.9% quarter-over-quarter, while maintaining an operating margin of +17.9% and return on equity of +14.2%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

Greenlight Capital Re, Ltd. (GLRE) Company Overview
About Greenlight Capital Re, Ltd.
Reinsurance company offering diverse property and casualty products.
The company operates as a property and casualty reinsurance provider, generating revenue by offering a wide range of reinsurance products and services to clients globally. It markets its products through reinsurance brokers, which allows it to reach various markets and clients effectively.
Incorporated in 2004 and headquartered in Grand Cayman, the company specializes in both standard and specialty reinsurance products, including automobile, casualty, and unique risks such as cyber and terrorism. This diversification in offerings helps mitigate risk and capitalize on different market demands.
Company Information
Sector
Financial Services
Industry
Insurance - Reinsurance
Employees
64
CEO
Mr. Greg Richardson
Country
Cayman Islands
IPO Year
2007
Website
greenlightre.comGreenlight Capital Re, Ltd. (GLRE) Latest News & Analysis
Greenlight Capital Re, Ltd. (NASDAQ:GLRE) will hold its Q3 2024 earnings call on November 5, 2024, at 9:00 AM ET, featuring key executives including CEO Greg Richardson and Chairman David Einhorn.
The earnings call provides insights into Greenlight Capital Re's financial performance, strategic direction, and leadership updates, which can influence investor sentiment and stock valuation.
The company reported a combined ratio of 95.9% and net income of $35.2 million, resulting in earnings of $1.01 per diluted share.
A combined ratio of 95.9% indicates strong underwriting performance, while net income and earnings per share of $1.01 suggest profitability, positively influencing investor confidence and stock value.
Greenlight Capital Re, Ltd. Schedules Third Quarter 2024 Financial Results and Conference Call
3 months agoGreenlight Capital Re, Ltd. (NASDAQ: GLRE) will release Q3 2024 financial results on November 4, 2024, with a conference call scheduled for November 5, 2024, at 9:00 a.m. ET.
The upcoming financial results and conference call for Greenlight Capital Re could impact stock prices and investor sentiment, reflecting the company's performance and future outlook.
AM Best Revises Outlooks to Positive for Greenlight Capital Re, Ltd. and Its Subsidiaries
3 months agoAM Best has upgraded the outlooks to positive for Greenlight Reinsurance and its Ireland subsidiary while affirming their Financial Strength Rating at A-. Greenlight Capital Re's outlook is also positive.
Positive outlook revisions and affirmed strong ratings for Greenlight Reinsurance indicate improved financial stability, potentially enhancing investor confidence and attracting new capital.
Greenlight Capital Re, Ltd. (NASDAQ:GLRE) will hold its Q2 2024 earnings conference call on August 7, 2024, at 9:00 AM ET, featuring key executives including David Einhorn and Faramarz Romer.
The earnings call provides insights into Greenlight Capital Re's financial performance and strategic direction, influencing investor sentiment and stock valuation.
The company reported a premium growth of 9.1% and will hold its 2024 Investor Day on November 19, 2024.
A 9.1% premium growth signals strong company performance, potentially boosting investor confidence and stock prices ahead of the upcoming Investor Day.
Frequently Asked Questions About GLRE Stock
What is Greenlight Capital Re, Ltd.'s (GLRE) stock forecast for 2025?
Analyst forecasts for Greenlight Capital Re, Ltd. (GLRE) are not currently available. The stock is trading at $13.52.
Is GLRE stock a good investment in 2025?
According to current analyst ratings, GLRE has 2 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $13.52. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for GLRE stock?
Price predictions from Wall Street analysts for GLRE are not currently available. The stock is trading at $13.52.
What is Greenlight Capital Re, Ltd.'s business model?
The company operates as a property and casualty reinsurance provider, generating revenue by offering a wide range of reinsurance products and services to clients globally. It markets its products through reinsurance brokers, which allows it to reach various markets and clients effectively.
What is the highest forecasted price for GLRE Greenlight Capital Re, Ltd.?
Price targets from Wall Street analysts for GLRE are not currently available. The stock is trading at $13.52.
What is the lowest forecasted price for GLRE Greenlight Capital Re, Ltd.?
Price targets from Wall Street analysts for GLRE are not currently available. The stock is trading at $13.52.
What is the overall GLRE consensus from analysts for Greenlight Capital Re, Ltd.?
The overall analyst consensus for GLRE is bullish. Out of 1 Wall Street analysts, 2 rate it as Buy, 1 as Hold, and 0 as Sell.
How accurate are GLRE stock price projections?
Stock price projections, including those for Greenlight Capital Re, Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.